VECTORB2B was established in 2019 as an organisation for research,
innovation and development The shareholders are a strong and complementary set of renowed academic and industrial partners
within the Portugal health sector
Together we form a robust asset
of Knowledge and Innovation
We work with biotechnology, pharma and medical device companies in providing single service or conducting a full or partial program. We can speed up your development program through continuous project management from bench to bedside providing flexible, tailored solutions. Services include discovery, pre-clinical studies, toxicology, CMC and full clinical trial services.
VECTORB2B provides highly qualified services of drug discovery and development from the bench to bedside (B2B).
It gathers the scattered capacities of the academic and industrial stakeholders within the Portuguese Health Sector to provide integrated services in drug discovery and screening, project design and implementation, pre-clinical and clinical scientific management, process development and GMP manufacturing.
VectorB2B is your partner for cost-efficient, rapid and strategic drug discovery & development.
Our specialists develop the best process for your needs, including galenic formulation and biologic cultures – from lab scale to GMP certified 50L disposable bioreactor
Let us support you in the fight against COVID-19 with our antibody development services and our clinical trial expertise or testing your molecules in neutralization assays in a P3 setting or in vivo models
VectorB2B stakeholders are a strong and complementary set of academic and industrial partners renowned in the Health Sector in Portugal. Together, we form a robust platform of knowledge and innovation, providing cutting-edge technology and expertise, adding value to our customers.
